™E Pharma Announces Oral Presentation of NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma at ESMO Congress 2024 By Investing.com Read more
Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead By Investing.com Read more
™E Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders By Investing.com Read more
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal By Reuters Read more